SC 13D

Company

TRINITY BIOTECH PLC

Filed

February 9, 2024

Accession Number

0001193125-24-030515

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →